Cargando…
Hereditary Colorectal Cancer Syndromes: Molecular Genetics and Precision Medicine
Colorectal cancer (CRC) is the third most commonly diagnosed cancer worldwide. Hereditary CRC syndromes account for approximately 5–10% of all CRC, with a lifetime risk of CRC that approaches 50–80% in the absence of endoscopic or surgical treatment. Hereditary CRC syndromes can be phenotypically di...
Autores principales: | Chen, Liuxiang, Ye, Liansong, Hu, Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776295/ https://www.ncbi.nlm.nih.gov/pubmed/36551963 http://dx.doi.org/10.3390/biomedicines10123207 |
Ejemplares similares
-
Molecular Diagnostics for Precision Medicine in Colorectal Cancer: Current Status and Future Perspective
por: Chen, Guoli, et al.
Publicado: (2016) -
Management of Patients with Hereditary Colorectal Cancer Syndromes
por: Brandão, Catarina, et al.
Publicado: (2015) -
Hereditary Colorectal Cancer: State of the Art in Lynch Syndrome
por: Nolano, Antonio, et al.
Publicado: (2022) -
Aspirin Colorectal Cancer Prevention in Lynch Syndrome: Recommendations in the Era of Precision Medicine †
por: Serrano, Davide, et al.
Publicado: (2022) -
Circulating tumor cells in colorectal cancer in the era of precision medicine
por: Hu, Mingchao, et al.
Publicado: (2021)